DiscoverMercalis in MotionThe Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know
The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

Update: 2023-07-19
Share

Description

The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations.  In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter. 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

TrialCard